Showing results (631-640 of 673) with videos related to

Sort By:
Pageof 68
Mycopathologia|August 11, 2023
Predictors for Prolonged Hospital Stay Solely to Complete Intravenous Antifungal Treatment in Patients with Candidemia: Results from the ECMM Candida III Multinational European Observational Cohort StudyMatthias Egger, Jon Salmanton-García, Aleksandra Barac, et al.
Cell Reports. Medicine|April 27, 2022
Development and validation of SCOPE score: A clinical score to predict COVID-19 pneumonia progression to severe respiratory failureEvangelos J Giamarellos-Bourboulis, Garyfallia Poulakou, Aline de Nooijer, et al.
Journal of Clinical Medicine|April 3, 2021
Prospective Study on Incidence, Risk Factors and Outcome of Recurrent Clostridioides difficile InfectionsGuido Granata, Nicola Petrosillo, Lucia Adamoli, et al.
Plos One|August 21, 2020
Tocilizumab and steroid treatment in patients with COVID-19 pneumoniaMalgorzata Mikulska, Laura Ambra Nicolini, Alessio Signori, et al.
The Journal of Antimicrobial Chemotherapy|August 22, 2023
Mortality in KPC-producing Klebsiella pneumoniae bloodstream infections: a changing landscapeDaniele Roberto Giacobbe, Cristina Marelli, Greta Cattardico, et al.
Science Advances|November 11, 2022
High-temporal resolution profiling reveals distinct immune trajectories following the first and second doses of COVID-19 mRNA vaccinesDarawan Rinchai, Sara Deola, Gabriele Zoppoli, et al.
Intensive Care Medicine|March 31, 2025
A consensus of European experts on the definition of ventilator-associated pneumonia recurrences obtained by the Delphi method: the RECUVAP studyAntoine Gaillet, Charles-Edouard Luyt, Jean-Francois Timsit, et al.
Mycoses|July 5, 2019
ECMM CandiReg-A ready to use platform for outbreaks and epidemiological studiesPhilipp Koehler, Maiken Cavling Arendrup, Sevtap Arikan-Akdagli, et al.
The Journal of Infection|October 17, 2025
Risk factors for persistent candidemia and prognostic implications: Results from the ECMM Candida III studySarah Sedik, Matthias Egger, Stella Wolfgruber, et al.
Intensive Care Medicine Experimental|June 29, 2025
29-mRNA host response signatures for classification of bacterial infection, viral infection and disease progression in COVID-19 pneumonia: a post hoc analysis of the SAVE-MORE randomized clinical trialEvdoxia Kyriazopoulou, Antigone Kotsaki, Asimina Safarika, et al.
Pageof 68